Neurological
Coronavirus delta variant is spreading rapidly in the United States
Subjects ” General neurology
HealthDay News – The delta variant of the coronavirus that once crippled India now accounts for 20 percent of infections in the United States, Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases, said Tuesday.
The percentage of the highly transmissible and potentially more dangerous variant has doubled in the past few weeks, Fauci said at a White House briefing on the virus on Tuesday, CNN reported. “As in [the alpha variant first seen in Britain], we seem to be following the pattern with the delta variant with a doubling time of around two weeks, ”he noted.
Fortunately, Pfizer and Moderna’s vaccines appear to be effective against the Delta variant, Fauci said, but the challenge is getting more people to take the vaccines, CNN reported. The Pfizer vaccine was 88 percent effective in preventing COVID-19 symptoms of the Delta variant two weeks after the second dose of the vaccine.
Continue reading
“If you look at hospital stays, both Pfizer-BioNTech and Oxford AstraZeneca are between 92 and 96 percent effective against hospital stays,” said Fauci.
CNN article
Subjects:
COVID19 General Infectious Diseases General Neurology
Would you like to read more?
Please log in or register first to view this content.
Login Register
to open
Next post in General Neurology
Shut down
Include more information on the rapid spread of the coronavirus delta variant in the United States
Loading…
Include more information on the rapid spread of the coronavirus delta variant in the United States
Loading…
Include more information on the rapid spread of the coronavirus delta variant in the United States
Loading…
Include more information on the rapid spread of the coronavirus delta variant in the United States
Loading…
Would you like to see more content from Neurology Advisor?
Register now for free to access unlimited clinical news with personalized daily tips for you, Full-length features, case studies, conference coverage, and more.
{{login-button}} {{register-button}}
Would you like to read more?
Please log in or register first to view this content.
Login Register